Objective-To determine whether the distribution of ABO blood groups in women with ovarian cancer differs from that in the general population in a large, defined English region. Design Data on blood groups for controls were available from three sources. These were: all patients in the ORLS whose blood group had been recorded between 1968 and 1978; all patients in the ORLS with a blood group recorded between 1979 and 1984; and blood donors in the Oxford region in 1988. ABO blood group distribution in each source were very similar, and we used the inpatient data for 1979-84 as the control data in the statistical analyses which follow.
About 4000 women die each year from ovarian cancer in England.' It is the commonest cause of death from cancer of the female genital tract in England and its prognosis is generally poor.2 3 Death rates increased in England during the first half of this century but have levelled off in recent decades. 4 5 It is commoner in western Europe and north America than in Japan, China, India, and south America. 6 The aetiology of ovarian cancer is largely unknown and its study is complicated by the many different histological types of tumour. There is a protective effect of parity and of the use of oral contraceptives.7 8 For some cases, it has long been suspected that there is a genetic influence. Clustering within families occurs. McGowan, for example, found that women with ovarian cancer were more likely than controls to have relatives with cancer of the female reproductive organs.9 There is also evidence that breast cancer and ovarian cancer may occur together in families more often than expected by chance. ' 
(100 0) (31-8) (56-1) (9 3) (2 8) Controls were the ORLS patients admitted during 1979-84 *Relative incidence differs from one at 5% level described by Mourant'5 citing Woolf. The ratio of the frequency of blood group A to 0 in the cases was calculated first, followed by the ratio of blood group A to 0 in the controls. The ratio of the AIO ratio for the cases to that for the control population was then calculated and, following Mourant, this was termed the relative incidence of A. In effect, this provides a measure of relative incidence of A to 0 blood groups in the cases after adjusting for the levels of A and 0 in the control population. If the cases and controls had the same blood group distributions in respect of A and 0, then the relative incidence would be one. A X2 statistic for the significance of the difference of the estimated relative incidence from one and its approximate confidence interval were calculated. Similar calculations were undertaken to compare the relative incidences of blood group B to 0 in cases and controls.
The heterogeneity of relative incidences estimated in subgroups of the cases (for example, comparing histological types, marital status groups, and parity groups) was assessed by X2 statistic.15 Relative The blood group distributions and relative incidences for groups A and B by histological tumour type are shown in table I. The relative incidences of A and B were greater than one in the patients with ovarian cancer. That for blood group A differed significantly from one (X2=7 0; df=1; p<0-01). The confidence intervals for the relative incidences for B were based on many fewer cases and were much wider than those for blood group A.
The relative incidence of blood group A in patients with adenocarcinoma was 1-15 (95% confidence interval 1-0, 1-3). Although special ovarian tumours and other epithelial tumours had lower relative incidences for A and B, numbers were small, the confidence intervals were wide, and these differences were not significant. Overall, the differences found in the relative incidences for both A and B, comparing different histological types, were not significant (X2 for A:O=5-4, B:O=2-7, 4 degrees of freedom).
In the general population, even within the United Kingdom, ABO 1-0 5-5 *Significant at the 5% level the controls, we used the blood group data on single women in the ORLS files as controls for nulliparous cases; and we used the blood group data on married women as controls for parous cases. As expected, nulliparous women had the lowest relative incidence but these differences were not statistically significant (table III) . We analysed the data on blood group, marital status, and parity again confining the analysis to women born in south and central England with the same result but a larger confidence interval.
Discussion
Mourant combined data on a total of 3175 cases from 24 studies in different populations worldwide to obtain a relative incidence for blood group A 
